A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2
Detection Principle
NucleicAcid-PCR based
Target
E, RdRP (In house); ORF1ab, E (Cobas); E, N2 (Xpert)
Testing Method Category
PCR_KIT
Testing Method
kit & in-house
Testing Method - Additional Info
Cobas 6800 system (Roche Diagnostics) & laboratory-developed test (LDT) designed at the British Columbia Centre for Disease Control (BCCDC) (Vancouver, BC) & Xpert Xpress SARS-CoV-2 assay (Cepheid)
Reported Performance
Specificity: 100% (all); Sensitivity: 94.4% (LDT, NasoPharingeal swabs), 100% ( commercial kit, NP swabs), 91.7 (LDT, OroPharingeal swabs), 88.9% (commercial kit, OP swabs)
Sample Size
190 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements